147 related articles for article (PubMed ID: 27241251)
1. A new era of thoracic oncology? Ex-vivo stereotactic ablative radiosurgery within Ex-vivo Lung Treatment System as a hybrid therapy for unresectable locally advanced pulmonary malignancies.
Henkenberens C; Zinne N; Biancosino C; Höffler K; Schmitto JD; Bremer M; Haverich A; Krüger M
Med Hypotheses; 2016 Jul; 92():31-4. PubMed ID: 27241251
[TBL] [Abstract][Full Text] [Related]
2. Stereotactic ablative radiotherapy for pulmonary oligometastases and oligometastatic lung cancer.
Shultz DB; Filippi AR; Thariat J; Mornex F; Loo BW; Ricardi U
J Thorac Oncol; 2014 Oct; 9(10):1426-33. PubMed ID: 25170641
[TBL] [Abstract][Full Text] [Related]
3. Available evidence on re-irradiation with stereotactic ablative radiotherapy following high-dose previous thoracic radiotherapy for lung malignancies.
De Bari B; Filippi AR; Mazzola R; Bonomo P; Trovò M; Livi L; Alongi F
Cancer Treat Rev; 2015 Jun; 41(6):511-8. PubMed ID: 25913714
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary oligometastases: metastasectomy or stereotactic ablative radiotherapy?
Widder J; Klinkenberg TJ; Ubbels JF; Wiegman EM; Groen HJ; Langendijk JA
Radiother Oncol; 2013 Jun; 107(3):409-13. PubMed ID: 23773410
[TBL] [Abstract][Full Text] [Related]
5. Stereotactic ablative radiotherapy (SABR) for non-small cell lung cancer.
Iyengar P; Westover K; Timmerman RD
Semin Respir Crit Care Med; 2013 Dec; 34(6):845-54. PubMed ID: 24258574
[TBL] [Abstract][Full Text] [Related]
6. Non-surgical treatment of lung cancer: personalised stereotactic ablative radiotherapy.
Tsang MW; Kam MK; Leung SF; Chan AT
Hong Kong Med J; 2014 Dec; 20(6):529-36. PubMed ID: 25256817
[TBL] [Abstract][Full Text] [Related]
7. CyberKnife stereotactic ablative radiotherapy for lung tumors.
Gibbs IC; Loo BW
Technol Cancer Res Treat; 2010 Dec; 9(6):589-96. PubMed ID: 21070081
[TBL] [Abstract][Full Text] [Related]
8. [Stereotactic radiotherapy for non-small cell lung cancer: From concept to clinical reality. 2011 update].
Girard N; Mornex F
Cancer Radiother; 2011 Oct; 15(6-7):522-6. PubMed ID: 21889901
[TBL] [Abstract][Full Text] [Related]
9. Stereotactic ablative body radiotherapy for lung cancer.
Franks KN; Jain P; Snee MP
Clin Oncol (R Coll Radiol); 2015 May; 27(5):280-9. PubMed ID: 25746732
[TBL] [Abstract][Full Text] [Related]
10. A Multidisciplinary Evaluation of a Web-based eLearning Training Programme for SAFRON II (TROG 13.01): a Multicentre Randomised Study of Stereotactic Radiotherapy for Lung Metastases.
Pham D; Hardcastle N; Foroudi F; Kron T; Bressel M; Hilder B; Chesson B; Oates R; Montgomery R; Ball D; Siva S
Clin Oncol (R Coll Radiol); 2016 Sep; 28(9):e101-8. PubMed ID: 27116931
[TBL] [Abstract][Full Text] [Related]
11. Stereotactic radiosurgery for a cardiac sarcoma: a case report.
Soltys SG; Kalani MY; Cheshier SH; Szabo KA; Lo A; Chang SD
Technol Cancer Res Treat; 2008 Oct; 7(5):363-8. PubMed ID: 18783285
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of single fraction stereotactic ablative radiotherapy for lung metastases.
Filippi AR; Badellino S; Guarneri A; Levis M; Botticella A; Mantovani C; Ragona R; Racca P; Buffoni L; Novello S; Ricardi U
Technol Cancer Res Treat; 2014 Feb; 13(1):37-45. PubMed ID: 23819496
[TBL] [Abstract][Full Text] [Related]
13. A radiation oncologist's and thoracic surgeon's view on the role of stereotactic ablative radiotherapy for operable lung cancer.
Timmerman RD; Fernando HC
Semin Thorac Cardiovasc Surg; 2013; 25(1):8-13. PubMed ID: 23800524
[TBL] [Abstract][Full Text] [Related]
14. Feasibility report of image guided stereotactic body radiotherapy (IG-SBRT) with tomotherapy for early stage medically inoperable lung cancer using extreme hypofractionation.
Hodge W; Tomé WA; Jaradat HA; Orton NP; Khuntia D; Traynor A; Weigel T; Mehta MP
Acta Oncol; 2006; 45(7):890-6. PubMed ID: 16982555
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Single-fraction and Multi-fraction Stereotactic Radiotherapy for Patients with 18F-fluorodeoxyglucose Positron Emission Tomography-staged Pulmonary Oligometastases.
Siva S; Kirby K; Caine H; Pham D; Kron T; Te Marvelde L; Whalley D; Stevens MJ; Foroudi F; MacManus M; Ball D; Eade T
Clin Oncol (R Coll Radiol); 2015 Jun; 27(6):353-61. PubMed ID: 25698068
[TBL] [Abstract][Full Text] [Related]
16. The evolving role of radiotherapy in treatment of oligometastatic NSCLC.
Bergsma DP; Salama JK; Singh DP; Chmura SJ; Milano MT
Expert Rev Anticancer Ther; 2015; 15(12):1459-71. PubMed ID: 26536370
[TBL] [Abstract][Full Text] [Related]
17. SABR for aggressive local therapy of metastatic cancer: A new paradigm for metastatic non-small cell lung cancer.
Westover KD; Iyengar P; Sharma AN; Timmerman R
Lung Cancer; 2015 Aug; 89(2):87-93. PubMed ID: 26028304
[TBL] [Abstract][Full Text] [Related]
18. [Radiotherapy promises: focus on lung cancer].
Jouin A; Durand-Labrunie J; Leroy T; Pannier D; Wagner A; Rault E; Lartigau E
Bull Cancer; 2013 Jun; 100(6):575-85. PubMed ID: 23719541
[TBL] [Abstract][Full Text] [Related]
19. Follow-up of patients after stereotactic radiation for lung cancer: a primer for the nonradiation oncologist.
Huang K; Palma DA;
J Thorac Oncol; 2015 Mar; 10(3):412-9. PubMed ID: 25695219
[TBL] [Abstract][Full Text] [Related]
20. CT perfusion imaging in response assessment of pulmonary metastases undergoing stereotactic ablative radiotherapy.
Sawyer B; Pun E; Samuel M; Tay H; Kron T; Bressel M; Ball D; Siva S
J Med Imaging Radiat Oncol; 2015 Apr; 59(2):207-15. PubMed ID: 25601133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
